Literature DB >> 21653204

Epizootic myocarditis associated with encephalomyocarditis virus in a group of rhesus macaques (Macaca mulatta).

K Masek-Hammerman1, A D Miller, K C Lin, J MacKey, H Weissenböck, L Gierbolini, A Burgos, H Perez, K G Mansfield.   

Abstract

Six cases of fatal myocarditis associated with encephalomyocarditis virus occurred over a 14-month period in a group of outdoor-housed juvenile rhesus macaques. All animals were younger than 3 years of age and died or were euthanized following acute onset of dyspnea or pulmonary effusion (3 of 6) or were found dead without premonitory signs (3 of 6). Gross findings included pulmonary congestion (6 of 6), variable degrees of pleural effusion (4 of 6), multifocal pale tan foci throughout the myocardium (3 of 6), hepatomegaly and hepatic congestion (3 of 6), and pericardial effusion (1 of 6). Histologically, affected myocardium was infiltrated multifocally by lymphoplasmacytic and histiocytic inflammation admixed with necrotic and degenerate myofibers and infrequent mineralization (6 of 6). Pulmonary edema was present in all animals. Encephalomyocarditis virus was confirmed in 6 of 6 hearts by immunohistochemistry, and virus was isolated from one case by polymerase chain reaction. Sequencing of virus isolated from 1 affected animal indicated infection with a novel encephalomyocarditis virus. Encephalomyocarditis virus should be considered as a differential etiology in outbreaks of myocarditis and pulmonary edema in juvenile primates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653204     DOI: 10.1177/0300985811409254

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  8 in total

1.  Molecular characterization of encephalomyocarditis virus strains isolated from an African elephant and rats in a French zoo.

Authors:  Aurore Romey; Benjamin Lamglait; Yannick Blanchard; Fabrice Touzain; Helene Quenault; Anthony Relmy; Stephan Zientara; Sandra Blaise-Boisseau; Labib Bakkali-Kassimi
Journal:  J Vet Diagn Invest       Date:  2020-12-08       Impact factor: 1.279

Review 2.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

3.  Evaluation of a duplex reverse-transcription real-time PCR assay for the detection of encephalomyocarditis virus.

Authors:  Shaomin Qin; Darren Underwood; Luke Driver; Carol Kistler; Ibrahim Diallo; Peter D Kirkland
Journal:  J Vet Diagn Invest       Date:  2018-06-02       Impact factor: 1.279

Review 4.  The encephalomyocarditis virus.

Authors:  Margot Carocci; Labib Bakkali-Kassimi
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

5.  Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice.

Authors:  Shu Zhu; Xin Guo; Lisa R Keyes; Hanchun Yang; Xinna Ge
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 6.  Research Relevant Conditions and Pathology in Nonhuman Primates.

Authors:  Chandra Saravanan; Thierry Flandre; Carolyn L Hodo; Anne D Lewis; Lars Mecklenburg; Annette Romeike; Oliver C Turner; Hsi-Yu Yen
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

7.  A highly divergent Encephalomyocarditis virus isolated from nonhuman primates in Singapore.

Authors:  Dawn Su-Yin Yeo; Jing Er Lian; Charlene J Fernandez; Yueh-Nuo Lin; Jasper Chin-Wen Liaw; Moi-Lien Soh; Elizabeth Ai-Sim Lim; Kwai-Peng Chan; Mah-Lee Ng; Hwee-Cheng Tan; Serena Oh; Eng-Eong Ooi; Boon-Huan Tan
Journal:  Virol J       Date:  2013-08-02       Impact factor: 4.099

8.  Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse Models.

Authors:  Osamu Kotani; Asif Naeem; Tadaki Suzuki; Naoko Iwata-Yoshikawa; Yuko Sato; Noriko Nakajima; Takushi Hosomi; Hiroyuki Tsukagoshi; Kunihisa Kozawa; Hideki Hasegawa; Fumihiro Taguchi; Hiroyuki Shimizu; Noriyo Nagata
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.